Use of Decision Modelling in Economic Evaluations of Diagnostic Tests: An Appraisal and Review of Health Technology Assessments in the UK [0.03%]
英国卫生技术评估中诊断试验经济评价的决策模型应用评估与回顾
Yaling Yang,Lucy Abel,James Buchanan et al.
Yaling Yang et al.
Diagnostic tests play an important role in the clinical decision-making process by providing information that enables patients to be identified and stratified to the most appropriate treatment and management strategies. Decision analytic mo...
Uterotonic Drugs for the Prevention of Postpartum Haemorrhage: A Cost-Effectiveness Analysis [0.03%]
预防产后出血的宫缩剂：成本效益分析
Karen Pickering,Ioannis D Gallos,Helen Williams et al.
Karen Pickering et al.
Objective: The objective of this study was to estimate the relative cost effectiveness for the full range of uterotonic drugs available for preventing postpartum haemorrhage (PPH). ...
Economics of Acromegaly Treatment in Brazil: A Budget Impact Analysis of Pituitary Surgery Compared with Long-Term Octreotide LAR [0.03%]
巴西肢端肥大症治疗的经济学分析：与长效奥曲肽相比，手术治疗的成本分析
Lara Benigno Porto,Ivan Ricardo Zimmermann,Luciana Ansaneli Naves
Lara Benigno Porto
Background: Acromegaly is a rare, chronic and debilitating disease whose treatment places a high burden on health systems. In the reality of the Brazilian public health network, many patients are kept on drug treatment be...
Patient and Physician Preferences for Therapy Characteristics for Psoriasis: A Discrete Choice Experiment in Japan [0.03%]
日本关于银屑病治疗特点的患者和医生倾向性离散选择实验
Timothy Bolt,Hisanori Kobayashi,Jörg Mahlich
Timothy Bolt
Background: With progress being made in the treatment of psoriasis, a variety of clinical research and treatment options are being pursued. This study used a discrete choice experiment (DCE) to estimate treatment characte...
Costs of Acute Headache Medication Use and Productivity Losses Among Patients with Migraine: Insights from Three Randomized Controlled Trials [0.03%]
急性头痛药物使用费用及 migrain患者生产力损失：三项随机对照试验的启示
Joshua K Porter,Gian Luca Di Tanna,Richard B Lipton et al.
Joshua K Porter et al.
Background: Migraine is associated with a substantial physical and emotional burden for patients. There is also a large economic burden associated with migraine, in terms of lost productivity and healthcare resource use. ...
Strimvelis® for Treating Severe Combined Immunodeficiency Caused by Adenosine Deaminase Deficiency: An Evidence Review Group Perspective of a NICE Highly Specialised Technology Evaluation [0.03%]
斯特里姆维尔司（Strimvelis）治疗腺苷脱氨酶缺陷所致严重联合免疫缺陷病：NICE高端技术评价的证据审查组观点报告
Emily South,Edward Cox,Nick Meader et al.
Emily South et al.
The Centre for Reviews and Dissemination and Centre for Health Economics Technology Assessment Group at the University of York was commissioned by the National Institute for Health and Care Excellence (NICE) Highly Specialised Technologies ...
Working with Patients and Members of the Public: Informing Health Economics in Child Health Research [0.03%]
与患者及公众合作：儿童健康研究中卫生经济学的信息来源
Rebecca Kandiyali,Annie Hawton,Christie Cabral et al.
Rebecca Kandiyali et al.
This paper considers patient and public involvement (PPI) in health economics research and how this might be facilitated. PPI refers to research carried out 'with' or 'by' members of the public and is now an important aspect of health resea...
Time and Cost of Hospitalisation for Salvage Therapy in Adults with Philadelphia Chromosome-Negative B Cell Precursor Relapsed or Refractory Acute Lymphoblastic Leukaemia in Spain [0.03%]
西班牙成人Ph阴性B细胞急性淋巴细胞白血病复发病人的挽救治疗住院时间和费用分析
Blanca Boluda,Rebeca Rodríguez-Veiga,David Martínez-Cuadrón et al.
Blanca Boluda et al.
Background: Philadelphia chromosome-negative (Ph-) relapsed or refractory (R/R) B-cell precursor acute lymphoblastic leukaemia (ALL) is rare, and information on its impact on healthcare systems is scarce. ...
Economic Burden of Patients Treated for Higher-Risk Myelodysplastic Syndromes (HR-MDS) in Routine Clinical Care in the United States [0.03%]
美国临床环境中根据风险程度较高的骨髓增生异常综合症（HR-MDS）治疗患者的经济负担
Jill A Bell,Aaron Galaznik,Marlo Blazer et al.
Jill A Bell et al.
Background and objective: Significant clinical burden is associated with higher-risk myelodysplastic syndromes (HR-MDS); however, the economic burden has not been fully examined. We examined cost of care and healthcare ut...